Additional information
1356839-89-8(free base)
White powder
NA
ACI-121112
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[[[(5S)-5-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-[(2S)-2-carboxypyrrolidin-1-yl]-6-oxohexyl]amino]carbonyl]-3-phenylpropyl]amino]hexanoyl] pyrrolidine-2-carboxylic acid trifluoro acetic acid (lisinopril dimer),
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[[[(5S)-5-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-[(2S)-2-carboxypyrrolidin-1-yl]-6-oxohexyl]amino]carbonyl]-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid trifluoro acetic acid
82.2-84.3°C
C42H60N6O9.C2HF3O2
906.98
Ambient
2-8°C
(S)-Lisinopril Dimer trifluoro acetic acid ; (2S)-1-[(2S)-6-Amino-2-[[(2S)-1-[[[(5S)-5-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-[(2S)-2-carboxypyrrolidin-1-yl]-6-oxohexyl]amino]carbonyl]-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic Acid trifluoro acetic acid ;
Angiotensin-converting enzyme (ACE) inhibitors
![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)
![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)
